Successful management of post-COVID-19 acanthamoebic encephalitis

Successful management of post-COVID-19 acanthamoebic encephalitis

Acanthamoebic encephalitis is a rare and highly fatal disease that has no standard management protocol. Coronavirus disease 2019 (COVID-19) causes immune dysfunction and may predispose patients to this infection.The present study describes successful management of acanthamoebic encephalitis in a you...

Full description

Bibliographic Details
Main Authors: Govinda Siripurapu, Sameer Abdul Samad, Saman Fatima, Naveet Wig, M.V. Padma Srivastava
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:International Journal of Infectious Diseases
Subjects:
Acanthamoeba
acanthamoebic encephalitis
miltefosine
COVID-19
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971221006020
Description
Summary:Acanthamoebic encephalitis is a rare and highly fatal disease that has no standard management protocol. Coronavirus disease 2019 (COVID-19) causes immune dysfunction and may predispose patients to this infection.The present study describes successful management of acanthamoebic encephalitis in a young male who recently recovered from COVID-19 using a combination of medical and surgical approaches.A combination of miltefosine with other agents with trophicidal and cysticidal activities should be used in the regimen. Surgical excision of the abscess should be undertaken whenever feasible.
ISSN:1201-9712

Similar Items